Literature DB >> 3113015

Effect of OKT3 on survival and rate of retransplantation.

B H Markus, J J Fung, R D Gordon, S Iwatsuki, C O Esquivel, L Makowka, T E Starzl.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3113015      PMCID： PMC2911144     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

1.  OKT3 in the reversal of acute hepatic allograft rejection.

Authors:  C O Esquivel; J J Fung; B Markus; S Iwatsuki; R D Gordon; L Makowka; J W Marsh; A G Tzakis; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066

2.  Impact of Orthoclone OKT3 on liver transplantation.

Authors:  J J Fung; B H Markus; R D Gordon; C O Esquivel; L Makowka; A Tzakis; T E Starzl
Journal:  Transplant Proc       Date:  1987-04       Impact factor: 1.066

3.  A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection.

Authors:  A B Cosimi; S I Cho; F L Delmonico; M M Kaplan; R J Rohrer; R L Jenkins
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066
  3 in total
  2 in total

1.  Liver retransplantation in adults: overall results and determinant factors affecting the outcome.

Authors:  P Morel; H L Rilo; A G Tzakis; S Todo; R D Gordon; T E Starzl
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

Review 2.  Muromonab CD3. A review of its pharmacology and therapeutic potential.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.